Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial
Discussion
The study will evaluate the feasibility of a randomized controlled trial investigating combined conventional and Chinese herbal medicine therapy for psoriasis vulgaris. The ingredients of YXBCM01 were selected based on literature, the expert opinion on herbal medicine and pre-clinical evidence, for instance Chinese herbal medicine possesses anti-inflammatory or antiproliferative properties.
Trial registration
Australian New Zealand Clinical Trials Registry ACTRN12614000493640. (Source: Trials)
Source: Trials - December 19, 2014 Category: Research Source Type: clinical trials
LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
Condition: Psoriasis Vulgaris (Plaque Psoriasis)Interventions: Drug: LEO 90100 aerosol foam; Drug: Aerosol foam vehicle; Drug: Calcipotriol BDP gel; Drug: Gel vehicleSponsor: LEO PharmaActive, not recruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2014 Category: Research Source Type: clinical trials
